Lipoprotein-Associated Phospholipase A2 and C-Reactive
Protein for Risk-Stratification of Patients With TIA

Lipoprotein-Associated Phospholipase
A 2 Activity and Risk of Recurrent Stroke

Lipoprotein-Associated Phospholipase A2

Activity Is Associated with Large-Artery
Atherosclerotic Etiology and Recurrent Stroke in
TIA Patients

Lipoprotein-associated phospholipaseA2 testing usefulness

among patients withsymptomatic

intracranialatheroscleroticdisease